Harbaoui Brahim, Courand Pierre-Yves, Defforges Alice, Khettab Fouad, Milon Hugues, Girerd Nicolas, Lantelme Pierre
Cardiology Department, European Society of Hypertension Excellence Center, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Université Lyon-1, Villeurbanne, France; Génomique Fonctionnelle de l'Hypertension Artérielle, Lyon, France;
Cardiology Department, European Society of Hypertension Excellence Center, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France;
Am J Hypertens. 2016 Feb;29(2):234-44. doi: 10.1093/ajh/hpv098. Epub 2015 Jun 25.
The prognostic value of screening multiple target organ damages (TODs) in hypertensive subjects has not been extensively studied. We estimated the prognostic value of considering 3 TODs in estimating the 10-year survival in hypertensive subjects.
At baseline 1,848 out of a cohort of 1,963 hypertensive patients had a previous cardiovascular disease (CVD) or assessments of 3 TODs: Modification in Diet in Renal Disease (MDRD) <60ml/min or albuminuria >300mg/day, Sokolow index >3.5 mV, and advanced hypertensive retinopathy (grades 3 and 4 of Keith-Wagener-Barker classification). The cohort was divided into 5 groups: 0 TOD (N = 978), 1 TOD (N = 308), 2 TODs (N = 94), 3 TODs (N = 30), and previous CVD (N = 438).
After 10 years of follow-up, we observed 418 deaths of which 254 from cardiovascular cause. The adjusted hazard ratios for the major cardiovascular risk factors showed a progressive risk associated with the number of TODs. For all-cause death, the hazard ratios [95% confidence intervals] vs. 0 TOD of the other 4 groups were 1.91 [1.39-2.63], 1.99 [1.28-3.10], 4.33 [2.42-7.72], and 3.09 [2.35-4.05], respectively. For cardiovascular death, the hazard ratios [95% confidence intervals] were of the same order of magnitude: 2.14 [1.38-3.32], 2.12 [1.15-3.89], 4.22 [1.83-9.72], and 4.24 [2.95-6.11], respectively.
Our results indicate that hypertensive patients with several TODs had a worst outcome. Thus, it seems important to screen for multiple TODs in hypertension; especially check for severe hypertensive retinopathy in patients with left ventricular hypertrophy (LVH) and renal damage.
在高血压患者中筛查多种靶器官损害(TODs)的预后价值尚未得到广泛研究。我们评估了考虑3种TODs对高血压患者10年生存率评估的预后价值。
在基线时,1963名高血压患者队列中的1848人有既往心血管疾病(CVD)或进行了3种TODs评估:肾脏病饮食改良(MDRD)<60ml/分钟或蛋白尿>300mg/天、索科洛夫指数>3.5mV以及重度高血压视网膜病变(Keith-Wagener-Barker分级3级和4级)。该队列分为5组:0种TOD(N = 978)、1种TOD(N = 308)、2种TODs(N = 94)、3种TODs(N = 30)以及既往有CVD(N = 438)。
经过10年随访,我们观察到418例死亡,其中254例死于心血管原因。主要心血管危险因素的校正风险比显示出与TODs数量相关的渐进性风险。对于全因死亡,其他4组与0种TOD相比的风险比[95%置信区间]分别为1.91[1.39 - 2.63]、1.99[1.28 - 3.10]、4.33[2.42 - 7.72]和3.09[2.35 - 4.05]。对于心血管死亡,风险比[95%置信区间]处于同一数量级:分别为2.14[1.38 - 3.32]、2.12[1.15 - 3.89]、4.22[1.83 - 9.72]和4.24[2.95 - 6.11]。
我们的结果表明,患有多种TODs的高血压患者预后更差。因此,在高血压患者中筛查多种TODs似乎很重要;尤其要对左心室肥厚(LVH)和肾损害患者检查是否存在重度高血压视网膜病变。